chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Swelling
Clinical narrative: Red, swollen left arm from shoulder to elbow.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Rash maculo-papular
Clinical narrative: Red, blotchy area left thigh area 2in around, mottled boarders, central "bulls eye" apparent at injection site. Elodel cream BID
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Lymphadenopathy, Skin ulcer
Clinical narrative: Patient received Varivax 0.5 cc SQ left arm on 8/26/02. On 9/12/02 developed reddened area (15mmx15mm) lymphandenopathy right auricular area, 8-10 vesicles left trunk and back, 2 lesions inner lower lip. No fever.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site induration, Injection site oedema, Pruritus
Clinical narrative: One day after vaccine. Pt developed itchy and swelling injection site. No fever PE indurated with Erythema about 5 cm around injection site.
Age: 5.7
Sex: M
Vaccine: DTAP
Symptoms: Feeling hot, Swelling
Clinical narrative: Swollen from shoulder to elbow for several days. Warm to touch. No other symptoms.
Age: 2.7
Sex: M
Vaccine: DTAP
Symptoms: Injection site swelling
Clinical narrative: Swollen from shoulder to elbow, No other symptoms
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Cerebellar ataxia, Coordination abnormal, Fall
Clinical narrative: Patient seen here in office on 6/26/02 with complaints of frequent falls. Diagnosed with coordination disorder. Seen by MD (Pediatric neurologist). Diagnosis of cerebellar ataxia.
Age: 5.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Feeling hot, Injection site erythema, Rash
Clinical narrative: Developed large area of erythema, warmth and associated rash on left thigh after injection. Resolved.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Pt had DTaP, IPV, MMR adm on 09/13/2002, DTaP adm. in right deltoid immunization. Redness approx 3 1/8, Swelling approx 2.
Age: 3.75
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: L arm red and swollen to elbow. Seen 9/12/02 and Motrin and cold packs advised. On 9/13/02 started on Zytrec tsp po qd.
Age: 4.25
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site induration, Injection site oedema
Clinical narrative: Swelling and induration on vaccination area-4x4cm area.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Infection
Clinical narrative: Breakthrough chicken pox post vaccine.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Pt had immunization for varicella on 8/2/01 and broke out with chicken pox on 9/10/02.
Age: 4.2
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Hypersensitivity, Injection site erythema, Injection site oedema, Injection site reaction
Clinical narrative: 9/6/02 woke up front side of arm swollen upper part where DTaP given came to HD referred to private physician. Went to MD and seen by physician assistant diagnosed with postule cellulitis started on Bactrim 200mg BID and alternate hot and ice for 20 mins to arm. On Sunday 9/8/02 arm more swollen and red taken to ER. Diagnosed with local allergic reaction to DTaP by ER doctor. ER doctor prescribed Pediapred dose pack. 4 tsp one day, 3 tsp for two days and 2 tsp for two days and 1tsp for one day. Swelling is dramatically better today 9/9/02 at 5:10pm. Also given one tsp Benadryl every 6 hrs until pediapred gone. Arm has a blister about 1/2" long x 1/4" mid way between shoulder.
Age: 2.5
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Injection site erythema, Injection site rash, Injection site swelling
Clinical narrative: 3: x 3 1/2" red, round, slightly raised rash at injection site of L thigh.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Fatigue, Pyrexia
Clinical narrative: High fever and rash, Tiredness
Age: 70.0
Sex: F
Vaccine: TD
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: Redness, swelling, sharp nerve pain-lasting for 6 days-required doctor's visit. Redness/swelling extended all the way down arm 6" past elbow. Treated with Benadryl/Claritin and Allegra.
Age: 4.6
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Injection site oedema, Injection site pain, Injection site reaction
Clinical narrative: 9/13/02 pt was brought by mother with R arm swelling. MD examined pt and dx cellulitis R upper extended arm. Rocephin 500mg IM inj given. Antibiotic by mouth and Benadryl given on 9/14/02. Mother brought child again c/o R A pain. Pt was referred to ER.
Age: 18.0
Sex: F
Vaccine: MMR
Symptoms: Convulsion, Headache, Injection site inflammation, Injection site urticaria, Loss of consciousness
Clinical narrative: 15 seconds post administration of vaccine, c/o burning at site and then headache. She then fainted. She then had tonic/clonic movement lasting five seconds of upper extremity. She became conscious in less than one minute of incident. 0.3cc of 1:1000 adrenalin given SQ above vaccine injection site. Pt slowly awoke when given. BP and HR stable throughout incident. A hive was noted at site of vaccine. Stayed in clinic 1 hr and gone and felt fine. Uft with mom.
Age: 18.0
Sex: F
Vaccine: MMR
Symptoms: Syncope
Clinical narrative: 15 seconds post administration of vaccine, c/o burning at site and then headache. She then fainted. She then had tonic/clonic movement lasting five seconds of upper extremity. She became conscious in less than one minute of incident. 0.3cc of 1:1000 adrenalin given SQ above vaccine injection site. Pt slowly awoke when given. BP and HR stable throughout incident. A hive was noted at site of vaccine. Stayed in clinic 1 hr and gone and felt fine. Uft with mom.
Age: 34.0
Sex: M
Vaccine: TD
Symptoms: Hypokinesia, Injection site erythema, Injection site induration, Injection site pain, Malaise
Clinical narrative: Large baseball size area induration and erythema at injection site. Moderate pain experienced w/ movement of affected arm. Low grade temp; generalized malaise. Treatment included Medrol dose pak to blunt immune response.
Age: 34.0
Sex: M
Vaccine: TD
Symptoms: Pyrexia
Clinical narrative: Large baseball size area induration and erythema at injection site. Moderate pain experienced w/ movement of affected arm. Low grade temp; generalized malaise. Treatment included Medrol dose pak to blunt immune response.
Age: 29.0
Sex: M
Vaccine: ANTH, MEN
Symptoms: Inflammation, Oedema, Skin irritation
Clinical narrative: RECEIVED 7 ANTHRAX SHOT, LAST SHOT (#6) WAS 15 FEB 00.  AFTER EACH PREVIOUS SHOT, ARM BECAME INCREASING INFLAMED AND IRRITATED.  ON THE 15 FEB 00 SHOT INFLAMATION WAS FROM SHOLDER DOWN PAST ELBOW.  AFTER 18 SEP 02 VAC SWELLING OCCURED WITHIN 1HR HR FROM ARM PIT TO RIGHT ABOVE ELBOW.  AFTER 48 HRS SEEN BY  HOSIPITAL.  DOCTOR NOT CONCERNED EVEN GIVEN PREVIOUS HISTORY OF INCREASING SERVERNESS IN SWELLING AND INFLATION AT SHOT LOCATION.  PERSCRIBED CETIRIZINE 10MG FOR ITCHING AND SWELLING.  ON 21 SEP SWELLING INCREASED TO MAX SIZE FROM ELBOW TO ARMPIT AND THE ENTIRE INSIDE BICEP OF ARM.  SWELLING BEGAN TO REDUCE THAT EVENING. MINOR REDNESS TODAY 2X4 SECTION ON INNER BICEP AND MARBLE SIZE LUMP AT INJECTION SITE 23 SEP 02.  NO REACTION TO MENIGITUS SHOT IN OTHER ARM.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Cough, Periorbital oedema, Sneezing
Clinical narrative: 20 minutes after vaccine patient developed swelling of eyes, sneezing and cough
Age: 4.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Erythema, Feeling hot, Injection site induration
Clinical narrative: WARM, REDDENED INDURATED AREA 75mm X 75mm ON LEFT DELTOID, FIRST NOTICED BY MOTHER 2 DAYS AFTER INJECTION.  PRESCRIPTION OF BENADRYL GIVEN.
Age: 1.16
Sex: M
Vaccine: DTP, HIBV, IPV, MMR
Symptoms: Autism, Pyrexia, Rash
Clinical narrative: When patient received the vaccines, within 24 hours he ran a high fever, he broke out into a severe rash that covered his entire body that lasted several days. We took him to the ER. Temp 103-104.
Age: 4.5
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Bone marrow depression, Ecchymosis, Petechiae, Thrombocytopenia
Clinical narrative: Vaccinated well child 4/26/02. On 5/14/02, presented with petechie and ecchymosis. Evaluated by hematology course 5/14/02 - 9/10/02. Required platelets transfusions. Bone marrow depletion. No dyspnsia.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Coma, Convulsion
Clinical narrative: Patient became unresponsive. 8/24/02 was transported via EMS to hospital. Treated for seizures (history of seizures) and cellulitis of leg from immunization.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site hypersensitivity, Pruritus
Clinical narrative: Area around DTaP injection red with swelling, afebrile, itching. Patient sent to local hospital for IV antibiotic.
Age: 1.3
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Injection site mass, Injection site oedema, Injection site pain, Rash maculo-papular, Tenderness
Clinical narrative: Swelling at site and surrounding area/ blotchy/tenderness to touch/large knot/painful/low grade fever - day after
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Crying
Clinical narrative: Prolonged crying began 1 hour after vaccines. Did not abate for 8 hours. Did not nurse for 10 hours. No fever (was on routine acetaminophen, first dose prior to vaccine).  Local care for left leg.  Treatment: Tylenol/ice
Age: 1.1
Sex: F
Vaccine: DTAP, HBHEPB, MMR, PNC, VARCEL
Symptoms: Convulsion, Pyrexia
Clinical narrative: Temp 105+ Febrile sz X 2 minutes the evening post vaccines.
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Injection site mass
Clinical narrative: Pin to bean size lump at right thigh injection site. No redness, no pain, no fever
Age: 0.3
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Pyrexia
Clinical narrative: Fever of 103 degrees.  No focal problem noted.  Treatment: Tylenol/Motrin.
Age: 0.3
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Urticaria
Clinical narrative: Received 2nd set of immunizations on Thursday. Friday am, child was covered with hives. No dyspnea of fever. By Saturday hives became worse and child was taken to ER. No other distress noted. Given Benadryl 12.5 mg and sent home.  By Tuesday, hives began to disappear and Friday- completely gone.
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Injection site hard-red and hot to touch. Applied warm compresses.
Age: 40.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth, Pyrexia
Clinical narrative: Upper arm became very sore and later became red, hard, and hot to the touch, Redness spread to armpit. Had a fever of 100 degrees F for 2 days, Soreness lasted 6 days.
Age: 31.0
Sex: F
Vaccine: HEPA
Symptoms: Headache, Hypoaesthesia, Muscle spasms, Sensation of heaviness, Throat tightness
Clinical narrative: Client reports approximately 10 minutes after administration, numbing in arm, heavy arm, arm cramps at site of administration. Complained of feeling heavy eyes, terrible headache and tight throat. Saw MD and given Benadryl, Naprosyn. Fiorocet, all PRN. All symptoms gone 09/14 at 12 AM except for headache.
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Injection site erythema, Injection site oedema, Tenderness
Clinical narrative: Arm redness and swelling along with tenderness from superior deltoid to superior elbow. Complete recovery with cool compresses and Tylenol.
Sex: M
Vaccine: DTAP, HIBV, MMR, VARCEL
Symptoms: Erythema, Pyrexia, Rash
Clinical narrative: 09/16/2002 Began fever up to 102 a on 09/13 and 09/14 down to 100.5. Rash began 09/14 pm on face moving to trunk today. 09/17/2002 9:50a rash over entire body, afebrile, slightly red ears. Mother reports child acting healthier. She reported he had been out in the sun over the weekend and thought that's why brought the rash on.
Age: 16.0
Sex: F
Vaccine: RUB
Symptoms: Unintended pregnancy
Clinical narrative: Varicella given to teen who got pregnant before 90 days period over.
Age: 39.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Fatigue, Malaise, Pyrexia, Vomiting
Clinical narrative: Fever 102, Fatigue, Vomited x1,Ill x 3days.
Age: 1.3
Sex: M
Vaccine: DTAP
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: Cellulitis left thigh, Treated with Keflex X 10 days.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Irritability, Pyrexia, Rash vesicular
Clinical narrative: Vesicular rash in crops  over torso, extremities, Fever to 100 (rectally) Irritability, Pt seen in office 09/11/02, 50-100 spots seen.
Age: 1.6
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Skin ulcer, Urticaria
Clinical narrative: Scattered urticarical lesions within 4 hours of receiving varicella vacxcine, Hx of fever previous 2 days, Afebrile at time of vaccine, Afebrile with rash
Age: 5.0
Sex: M
Vaccine: DTPHIB, HEP, OPV, VARCEL
Symptoms: Rash vesicular
Clinical narrative: Rash on face, arms, chest and back. Physician diagnosed as varicella.
Age: 87.0
Sex: F
Vaccine: PPV
Symptoms: Musculoskeletal stiffness, Pain
Clinical narrative: Patient developed right arm pain and stiffness two hours after vaccination. Slowly recovering after two days. No treatment.
Age: 56.0
Sex: F
Vaccine: RAB, TD
Symptoms: Feeling hot, Injection site induration, Musculoskeletal discomfort, Swelling, Tenderness
Clinical narrative: 9/16/02 6 PM At follow up visit for #3 rabies vaccine, she complained of discomfort of left deltoid muscle. Area swollen, hot, indurated (measuring 70mmx70mm) On 9/2/02 had received Td vaccine; also, some edema and tenderness of lower part of upper left arm around outer aspect of elbow. She noticed onset of all symptoms about 3 to 4 days ago. Didn't take temperature but felt she did not have fever, no numbness, tingling of the extremity. Temperature 99.3 (ear) tried ice without relief. Now using heat, Tylenol.
Age: 29.0
Sex: F
Vaccine: MEN
Symptoms: Injection site swelling, Urticaria
Clinical narrative: Swelling and hives on left upper arm and back.
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Chest pain, Hypoaesthesia, Pruritus, Pyrexia, Urticaria
Clinical narrative: Hives, fever, numbess in lips, itching pain in chest.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling, Tenderness
Clinical narrative: 10x10cm left deltoid swelling, red, tender area. Noted 24 hours after receiving immunizations. On 8/21/02 DTaP given in left deltoid, IPV given in left upper arm.
Age: 46.0
Sex: F
Vaccine: HEP
Symptoms: Myalgia
Clinical narrative: On 06/06/2002, pt states during the course of the day her hand grip became painful to her left arm and area right above the elbow. States it feels tender and has had this everyday including this day (?) reporting event 06/20/02, No bruises noted
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Red, swollen area, slightly warm to touch 2-3 inch diameter. Soreness in leg. Patient seems ok. Running and playing. No other complaints.
Age: 1.5
Sex: F
Vaccine: DTAP, VARCEL
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Palm size induration, redness.
Age: 4.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Evening of 08/28/02, mother reported the child ran a temperature of 101 degrees F, Resolved next am,  On 09/12/02 left arm tender, red, swollen, ands warm to touch. Scab at site, Seen at doctor's office by nurse practitioner  Further information states "PHN spoke with nurse in doctor's office to obtain information related to treatment and recovery. The nurse states that notes in the chart indicate the area affected measured 2 cm by 3 cm. Keflex was ordered in addition to warm soaks. A follow up appointment was scheduled for Monday 09/16/02. PHN attempted to reach the office by phone on several occasions. On Friday, 09/20/02, I spoke with a RN at doctor's office who indicated that another follow uo appointment is scheduled for 09/23/02. She was unable to give any further information.
Age: 4.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Rash
Clinical narrative: Evening of 08/28/02, mother reported the child ran a temperature of 101 degrees F, Resolved next am,  On 09/12/02 left arm tender, red, swollen, ands warm to touch. Scab at site, Seen at doctor's office by nurse practitioner  Further information states "PHN spoke with nurse in doctor's office to obtain information related to treatment and recovery. The nurse states that notes in the chart indicate the area affected measured 2 cm by 3 cm. Keflex was ordered in addition to warm soaks. A follow up appointment was scheduled for Monday 09/16/02. PHN attempted to reach the office by phone on several occasions. On Friday, 09/20/02, I spoke with a RN at doctor's office who indicated that another follow uo appointment is scheduled for 09/23/02. She was unable to give any further information.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Developed chicken pox.
Sex: M
Vaccine: HEP
Symptoms: Crohn's disease, Urticaria
Clinical narrative: Onset hives 24 hours after HBV #3 and exacerbation of previously diagnosed Crohn's disease over following week. HBV #1 and #2 on 7/22/99 and 8/31/00 without problems.
Age: 20.0
Sex: F
Vaccine: TD
Symptoms: Blood pressure increased, Erythema, Heart rate increased, Pyrexia, Tinnitus
Clinical narrative: As described by mother: Popping noise in ears, couldn't hear vision blurred and was very bright, had red, blotchy rash with hives, heart racing, blood pressure evelated, lips blue, shaky, low grade fever. Saw doctor.
Age: 20.0
Sex: F
Vaccine: TD
Symptoms: Tremor, Urticaria, Vision blurred
Clinical narrative: As described by mother: Popping noise in ears, couldn't hear vision blurred and was very bright, had red, blotchy rash with hives, heart racing, blood pressure evelated, lips blue, shaky, low grade fever. Saw doctor.
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Joint stiffness, Pyrexia, Rash
Clinical narrative: Elevated temp, Rash on throat/neck area, Arms stiffness in joints, Joint pains,especially legs Benadryl ordered.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site oedema, Injection site warmth
Clinical narrative: Area/leg around DTaP injection swollen and hot to touch. Given antibiotics by mouth.
Age: 1.4
Sex: M
Vaccine: DTAP, HBHEPB, MMR
Symptoms: Injection site induration, Injection site oedema, Injection site pain, Screaming
Clinical narrative: Swelling in L thigh 8 1/2x12cm induration at 48 hours-inconsolable crying x 12hrs, afebrile with max induration. Medial at sore of DTaP.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Body temperature increased, Hyperaemia
Clinical narrative: Hypermia, increase temp L deltoid area 8/22 and 8/23. Injection given 8/21. Also had Pneumovax 1991 without problems
Age: 0.5
Sex: M
Vaccine: DTAP, HBHEPB, IPV, VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site haemorrhage, Injection site oedema, Injection site reaction
Clinical narrative: L thigh swollen, red, slightly ecchymotic 11x12cm observe possibly treat with Keflex for cellulitis.
Age: 4.25
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: Immunizations given on 9/10/02. Client returned to clinic on 9/11/02 with c/o red, swollen arm, warm to touch and slightly painful. Client's grandmother present with client, states that she first noticed that pt's arm was swollen, red and warm in the arm of 9/11/02. L arm red, warm to touch with swelling one inch. Client examined by MD given prescription for Amoxicillin.
Age: 0.5
Sex: U
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Erythema/swelling at site of DPT 18 hrs post vaccine.
Age: 1.0
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Feeling abnormal, Insomnia, Irritability, Nervous system disorder
Clinical narrative: At three weeks of age, pt became extremely irritable, did not want to eat, did not sleep or rest easily, and spit up. He never was content. Numerous trips to pediatrician, GI consult, GI testing (upper GI series, ultrasound, ph probe) done. Nothing significant showed on tests. Shows lack of responsiveness, little bonding, speech and language delays. Screened for early intervention and evaluated for speech and language (7 months behind). At 14 months 3/02, pt was diagnosed with mercury poisoning.
Age: 1.0
Sex: M
Vaccine: HEP
Symptoms: Neurodevelopmental disorder, Vomiting
Clinical narrative: At three weeks of age, pt became extremely irritable, did not want to eat, did not sleep or rest easily, and spit up. He never was content. Numerous trips to pediatrician, GI consult, GI testing (upper GI series, ultrasound, ph probe) done. Nothing significant showed on tests. Shows lack of responsiveness, little bonding, speech and language delays. Screened for early intervention and evaluated for speech and language (7 months behind). At 14 months 3/02, pt was diagnosed with mercury poisoning.
Age: 46.0
Sex: M
Vaccine: PPV, TD
Symptoms: Hyperhidrosis, Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: Pneumovax 9/12/02 L deltoid soreness later that day and increase erythema down arm, feverish, sweaty.
Age: 4.9
Sex: F
Vaccine: DTAP, MMR
Symptoms: Urticaria
Clinical narrative: Two hours after administration pt developed urticaria which has persisted for one month.
Age: 1.3
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Urticaria
Clinical narrative: 11:45am bright red area 4"x4" at and around injection site. 12:00 noon area of redness reduced in size to 2"x2" with 1" welt noted in center. 12:15pm area reduced to 1 1/2"x 1 1/2: with 1/2" welt much less red. 12:25pm MD discharged pt from office to home. No other signs and symptoms noted. No tx given.
Age: 3.2
Sex: F
Vaccine: RUB
Symptoms: Dermatitis bullous
Clinical narrative: 50 + vesicular lesions trunk, face, scalp.
Age: 3.0
Sex: M
Vaccine: UNK
Symptoms: Dermatitis bullous
Clinical narrative: 75-100 vesicular lesions all over body, scalp, inside mouth.
Age: 20.0
Sex: F
Vaccine: MEN
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site induration, Injection site warmth, Pruritus
Clinical narrative: Approx. 7 hrs post Menomune injection, developed red indurated lesion at site measuring 3 inches with 3 inches of erythema surrounding it. Area itches, was warm to touch. Lasted 24 hours.
Age: 2.0
Sex: F
Vaccine: DTAP, HIBV, MMR
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site reaction
Clinical narrative: Redness/induration of R upper arm at inj site minimally tender to palpation. Dx IM immunization reaction (local).
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Agitation, Headache, Nausea
Clinical narrative: Child c/o headache approx 2 hrs after immunizations. H/A worsened throughout the day and became excruciating by 6pm (8 hrs post shots). Child was crying and holding head. Given liquid Advil with slight relief. Child c/o HA until she fell asleep at 2am. Awoke the next am with slight HA and nausea which went away by mid morning.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Injection site erythema, Injection site reaction
Clinical narrative: Localized erythema and swelling above and around deltoid noted by mom a day and a half after vaccination. 10 days later still with 10cm x 8cm erythema. Treated with few day Augmentin for mild cellulitis. Still slight redness.
Age: 4.75
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Injection site inflammation, Injection site oedema, Injection site pain, Injection site reaction
Clinical narrative: Child given vaccination on 9/13/02. Mother was instructed to apply cool compresses to arm in pm followed by heat next day. Mother brings child into clinic on 9/16/02 to pick up a referral and reported that child's arm was sore. Mother informed nurse that arm became sore over the week-end. Questioned mother-did not do follow up with instruction nurse told her on 9/13/01. Child's arm red, swollen and warm to touch upper arm deltoid inflammed. Referred to PMD-treated for cellulitis 9/16/02 (Keflex-antibiotic).
Age: 4.75
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site warmth
Clinical narrative: Child given vaccination on 9/13/02. Mother was instructed to apply cool compresses to arm in pm followed by heat next day. Mother brings child into clinic on 9/16/02 to pick up a referral and reported that child's arm was sore. Mother informed nurse that arm became sore over the week-end. Questioned mother-did not do follow up with instruction nurse told her on 9/13/01. Child's arm red, swollen and warm to touch upper arm deltoid inflammed. Referred to PMD-treated for cellulitis 9/16/02 (Keflex-antibiotic).
Age: 44.0
Sex: F
Vaccine: TTOX
Symptoms: Headache, Injection site erythema, Injection site oedema, Injection site pain, Musculoskeletal stiffness
Clinical narrative: Pt reports after receiving shot applied alcohol after getting home noticed after she would apply alcohol arm was getting sore, felt warm and started to swell. Dr presentation to clinic Lt arm at injection site red, edematous. Pt also reports back on neck sore and stiff with HA's started post being immunized also c/o nausea. Pt instructed if symptoms change or worsen to RTC.
Age: 44.0
Sex: F
Vaccine: TTOX
Symptoms: Nausea
Clinical narrative: Pt reports after receiving shot applied alcohol after getting home noticed after she would apply alcohol arm was getting sore, felt warm and started to swell. Dr presentation to clinic Lt arm at injection site red, edematous. Pt also reports back on neck sore and stiff with HA's started post being immunized also c/o nausea. Pt instructed if symptoms change or worsen to RTC.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: In today 9/16/02 with twenty vesicular lesions-generalized. Rash began yesterday. Received Varivax given on 6/5/02.
Age: 26.0
Sex: F
Vaccine: HEP
Symptoms: Injection site pain, Neck pain
Clinical narrative: C/O aching pain starting approx this after Hep B #1 administration by Biojector Radiating from site of injeciton (R deltoid) to neck. Pain continued (shooting pain) approx 2 1/2 weeks. No relief with Ibuprofen, no swelling, no erythema, no fever.
Age: 1.25
Sex: F
Vaccine: DTAPH, VARCEL
Symptoms: Rash
Clinical narrative: Pt received her varicella vaccine and Tripedia DTaP/HIB combo at 1330 9/17/02 at approx 1600 pt's mother brought pt back with rash from head to toe. No respiratory problems. Tx with Benadryl.
Age: 1.5
Sex: F
Vaccine: DTAP
Symptoms: Irritability, Pyrexia, Sleep disorder
Clinical narrative: Fever 101, irritable, did not sleep well last pm.
Age: 17.0
Sex: F
Vaccine: HEP, TD
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Rt arm sore, red, hot for two days since Td, arm with HEB OK. Rt has a erythematous, warm area 5x3. Ampicillin  and Benadryl.
Age: 1.4
Sex: M
Vaccine: DTAP, HIBV, IPV
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site reaction
Clinical narrative: Child received IPV 2 days ago Lt thigh (5/8 needle length) swelling Lt thigh x 1 day. No known trauma. Insect-bite before IPV. Rt thigh swollen slightly increase temp. mod. erythematous. Rt circumference thigh 5cm x 10cm above knee. Rt 19.5x 25cm. Lt 23x 26cm. Child walks without limp. Rt knee-not swollen. Motrin 100mg, 5mls, 5mls po q 5 x 5 days. L thigh swollen immunizations on 9/18/02. Start Keflex. Cellulitis, vaccine reaction.
Sex: M
Vaccine: LYME
Symptoms: Headache, Vomiting
Clinical narrative: This report describes headache in a male vaccinee of unspecified age who received Lyme disease vaccine OspA recombinant (Lymerix). This report was received from the vaccinee and had not been verified by a physician or other health care professional. Medical history, concurrent conditions, and concurrent medications were unknown. On an unspecified date, the vaccinee received his first injection of Lymerix. Reportedly, 36 hours later, the vaccinee experienced "severe headache and vomiting". The vaccinee reported that the he went to the emergency room, where he was kept for his symptoms which lasted 12 hours. The vaccinee stated that he received a second injection of Lymerix. Reportedly, the symptoms did not recur, because he took unspecified "pain killers" 24 hours before and after the second Lymerix injection as prescribed by his doctor. As of 04/26/02, the events had resolved. The adverse events "headache" does not meet serious criteria, but is being submitted as an expedited report by special FDA request per the 06/28/00 letter. As of 4/26/02, the events had resolved.
Age: 50.0
Sex: M
Vaccine: LYME
Symptoms: Headache, Sinus congestion
Clinical narrative: This report describes headache in a 50 year old male who received Lyme disease vaccine recombinant OspA (Lymerix). It  was received from the vaccinee and has not been confirmed by a physician or other heathcare professional. Medical history and concurrent were not specified. reportedly. The vaccinee received no concomitant medications or vaccines. On 02/19/02, the vaccinee reportedly received his first injections of Lymerix. He  stated that on 02/20/02, he experienced headache and sinus "issues". The subject was reportedly seen by a physician. The reporter stated that the headaches resolved on 02/20/02, and the sinus "issues" improved. The Lymerix series was reportedly discontinued. The adverse event "headache" does not meet ICH serious criteria, but is being submitted as an expedited report by special FDA request per the 06/20/00 letter.
Sex: M
Vaccine: LYME
Symptoms: Hypoaesthesia, Neuropathy
Clinical narrative: This report describes neuropathy in a male vaccinee of unspecified age who received Lyme disease vaccine recombinant OspA (Lymerix). The vaccine's medical history, concurrent medications and concurrent medications were not specified. The vaccinee received his first and second injections of Lymerix without adverse event. In 05/2000, he received his third injection of Lymerix. the reporting rheumatologist stated that it was reported to her that the patient developed neuropathy and numbness "soon after" the third injection of Lymerix; however, she did not see the patient until 15 months later. As of 04/30/02, the events persisted. The adverse event 'neuropathy" does not meet ICH serious criteria, but is being submitted as an expedited report by special FDA request per the 06/28/00 letter.
Sex: F
Vaccine: LYME
Symptoms: Arthritis
Clinical narrative: This report describes arthritis in a female of unspecified age who received Lyme disease vaccine recombinant  OspA (Lymerix). Medical history, concurrent conditions and concurrent medications were not specified. On an unspecified date, the vaccinee received her second injection of Lymerix. At an unspecified time, post-vaccination, she experienced arthritis. As of 04/17/02, the event persisted. The adverse event 'arthritis' does not meet ICH serious critertria but is being submitted as an expedited report by special FDA request per the June 28, 2000 letter.
Age: 67.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia, Myalgia, Swelling
Clinical narrative: This report describes joint pain in a 67 year old female who received Lyme disease vaccine recombinant OspA(Lymerix) It was received from the vaccinee and has not been verified by a physician or other healthcare professional. Reportedly, the vaccinee had no relevant medical history, received no concurrent medications, and had no known allergies. She had no history of Lyme disease and did not have gout, psoriasis, or Crohn 's disease. There was no family history of rheumatoid arthritis or lupus. The vaccinee stated that in April 1999 and in May 1999 she received her first and second injections of Lymerix respectively w/out adverse event. the vaccinee stated that in May, 2000, she received her third injection of Lymerix. Starting in April, 2001. the vaccinee experienced muscular pain in her neck, upper arms and left shoulder which radiated to her right shoulder. She also experienced swelling in her hands. She stated that her symptoms were particularly severe in the morning and after resting or riding in a car. On 04/02/02, the patient awoke with left ankle swelling "The patient's symptoms were treated with a 5 week course of rofecoxib (vioxx) in fall 2001 and a 5 week course of celecoxib (Celebrex) in winter, 2002 with no relief. As of 04/03/02, the events persisted. The adverse events "joint pain" and "joint swelling" do not meet ICW serious criteria, but are being submitted as an expedited report by special FDA request per the 06/28/00 letter.
Age: 29.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Influenza like illness
Clinical narrative: This report describes joint pain in a 30 year old male who received Lyme disease vaccine recombinant OspA (Lymerix). This was received from the vaccinee and has not been verified by a physician or other healthcare professional. Medical history, concurrent conditions and concurrent medications were not specified. Reportedly, in April, 1999, the vaccinee received his first injection of Lymerix without adverse event. In October, 1999,the vaccinee reportedly received his second dose of Lymerix. He reported subsequently, in October, 1999, he experienced painful joints and knee pain and flu-like symptoms The flu-like symptoms reportedly resolved in Octoiber, 1999. Lymerix was discontinued. As of 04/02/02, the painful joints and knee pain were reportedly persisting. The adverse events 'joint pain' does not meet ICH serious criteria, but is being submitted as an expedited report by special FDa request per the 06/28/00 letter.
Sex: F
Vaccine: LYME
Symptoms: Headache, Joint stiffness
Clinical narrative: This report describes headaches in a female vaccinee of unspecified age who received Lyme disease vaccine recombinant OspA (Lymerix). It was received from the vaccinee's husband and has not verified by a physician or other healthcare professional.  Medical history, concurrent conditions and concurrent medications were not specified. In October, 1999, the vaccinee received her second injection of Lymerix. Subsequently, she experienced headaches and neck stiffness which persisted as of 04/02/02. The adverse event 'headache' does not meet ICH serious criteria, but is being submitted as an expedited report by special FDA request per the June 28, 2000 letter.
Sex: F
Vaccine: LYME
Symptoms: Arthritis
Clinical narrative: This report describes arthritis in a female of unspeicified age who received Lyme disease vaccine recombinant OspA (Lymerix). It report was received from the vaccinee and had not been verified by a physician or other healthcare professional. The medical history, concurrent conditions  and concurrent medications were not specified. On an unspecified date, the vaccine received an injection of Lymerix; it was not known if she had received previous injections of Lymerix. The reporter stated that subsequent to her Lymerix vaccination she had "some' arthritis". As of 05/03/02, the outcome of the event was unknown. Additional information will not be available.
Age: 61.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia
Clinical narrative: This report describes arthralgia in a 61 year old male who received Lyme disease vaccine recombinant OspA (Lymerix). It was received from the vaccinee's wife and has not been verified by a physician or other healthcare professional. The medical history, concurrent conditions and concurrent medications were not specified. The vaccinee had not experienced any adverse events following previous vaccinations. Following the second Lymerix injection, in 03/99, the vaccinee received his third injection of Lymerix in March 2000 and in March 2000, the pain in his hips and shoulders reportedly worsened. The vaccines was reportedly seen by his physivcian. As of 05/25/02, the hip and shoulder pain persisted. The adverse event "arthralgia" does not meet serious criteria, but is being submitted as an expedited report by special FDA request per the 06/28/00 letter.
Sex: U
Vaccine: LYME
Symptoms: Arthritis
Clinical narrative: This report describes arthritis in a vaccine of unspecified age and gender who received Lyme disease vaccine recombinant OspA (Lymerix). The medical history, concurrent conditions and concurrent medications were unknown. The vaccinee had "no problems" following the first injection of Lymerix. Information regarding the second injection was not provided. On an unspecified date, the vaccinee received the third Lymerix injection. Subsequently, the vaccine experienced arthritis with joint pain. The vaccinee was seen by a physician. The reporter stated that these events were possibly related to lymerix. As of 05.03/02, the outcome of the event was unknown. The adverse event "arthritis" does not meet serious criteria, but is  being submitted as an expedited report  by special FDA request per the 06/28/00 letter.
Age: 4.7
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: R thigh red, swollen, hot to touch. Redness measured 11x19.5cm. Benadryl given in office Rx for Atarax and Orapred x 5 days.
Age: 4.5
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Very red and swollen-hot to touch at injection site. Given Benadryl and Keflex x 10 days.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Redness, hot to touch at injection site. Given Benadryl and Orapred x 5 days.
Sex: M
Vaccine: FLU3
Symptoms: Face oedema, Rash, Urticaria
Clinical narrative: A pharmacist reported that a male patient received an injection of influenza virus vaccine (manufacturer unknown) "ten years ago." Approximately 24 hours post vaccination, the patient developed swollen lips, a rash and hives. He was seen by  a physician. No furter information was available at the date of this report.
Age: 4.0
Sex: F
Vaccine: DTAP, MMR, UNK
Symptoms: Oedema
Clinical narrative: Whole limb swelling of right arm
Age: 4.0
Sex: F
Vaccine: DTAP, MMR, UNK
Symptoms: Oedema peripheral
Clinical narrative: Whole limb swelling of right arm
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Oedema
Clinical narrative: Right leg whole thigh swelling
Sex: M
Vaccine: HEP
Symptoms: Neurodevelopmental disorder
Clinical narrative: Information has been received from a pharmacist concerning a male pt who in April 1993 was vaccinated with a dose of hep B vaccine recombinant. (lot number 15560 reported, invalid for the product). Subsequently, the pt developed learning disabilities.. The pt sought unspecified medical attention. Upon internal review, learning disabilities were determined to be an other important medical event. Additional info is not expected.
Age: 1.0
Sex: M
Vaccine: DTAP, HEP, HIBV
Symptoms: Abnormal behaviour, Cognitive disorder, Coma, Drug toxicity, Drug withdrawal syndrome
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning an approximately 12 month old male child who on 1/25/95 was vaccinated IM with his third dose of hep B vaccine recombinant lot 611468/0653A given on 1/25/95; lot 613800/1291A given on 3/27/95 and 5/26/97. An immunization record indicated that the pt was also vaccinated IM with four dose of Tripedia (lot 3C51043 given on 1/25/95, lot 4A61098 given on 3/27/95 and 5/26/95 and lot U031 given on 12/19/00; one dose of Tetramune lot 429-969 given on 1/29/96 and three doses of HibTITER lot 305lF given on 1/2/95; lot 265LJ given on 3/27/95, lot 005LK given on 5/26/95. It was noted that all of these vaccinations contain the mercury laden preservative thimerasol. It is alleged that due the accumulation of mercury in his body and the resultant mercury toxicity, the pt at approximately 12 months of age was neurologically devastated and "suddenly regressed developmentally, losing milestones and neurological development previously achieved, specifically including, but not limited to, becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior, and the loss of language skills, motor skills and affect." Upon internal review the pt's mercury toxicity, neurological devastation, withdrawn/unresponsive behavior, inability to speak, repetitive behavior and loss of language skills, loss of motor skills and loss of affect were determined to be other important medical events. Additional info is expected.
Age: 1.0
Sex: M
Vaccine: DTAP, HEP, HIBV
Symptoms: Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning an approximately 12 month old male child who on 1/25/95 was vaccinated IM with his third dose of hep B vaccine recombinant lot 611468/0653A given on 1/25/95; lot 613800/1291A given on 3/27/95 and 5/26/97. An immunization record indicated that the pt was also vaccinated IM with four dose of Tripedia (lot 3C51043 given on 1/25/95, lot 4A61098 given on 3/27/95 and 5/26/95 and lot U031 given on 12/19/00; one dose of Tetramune lot 429-969 given on 1/29/96 and three doses of HibTITER lot 305lF given on 1/2/95; lot 265LJ given on 3/27/95, lot 005LK given on 5/26/95. It was noted that all of these vaccinations contain the mercury laden preservative thimerasol. It is alleged that due the accumulation of mercury in his body and the resultant mercury toxicity, the pt at approximately 12 months of age was neurologically devastated and "suddenly regressed developmentally, losing milestones and neurological development previously achieved, specifically including, but not limited to, becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior, and the loss of language skills, motor skills and affect." Upon internal review the pt's mercury toxicity, neurological devastation, withdrawn/unresponsive behavior, inability to speak, repetitive behavior and loss of language skills, loss of motor skills and loss of affect were determined to be other important medical events. Additional info is expected.
Age: 1.2
Sex: M
Vaccine: HEP
Symptoms: Abnormal behaviour, Cognitive disorder, Coma, Drug toxicity, Drug withdrawal syndrome
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning an approximately 18 month old child who on 9/20/96 was vaccinated IM with hep B vaccine recombinant (lot 619858/0531D). An immunization record indicted that the pt was also vaccinated IM with Tetramune (lot 431-966 on 2/28/96); a first and second dose of Tripedia lot 7G8I484 given on 8/14/97, and lot 077I830 given on 4/24/96; one dose of HIB conjugate vaccine lot M3309L and a first and second dose of hep B vaccine lot 1950A2 given on 1/18/96 and lot 1965A2 given on 2/28/96. It was noted that all of these vaccinations contain the mercury laden preservative thimerosal. It is alleged that due to mercury toxicity that resulted from exposure to therefore mentioned vaccines, that on around July 1997, when the pt was approximately 18 months of age, he "suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior, and the loss of language skills, motor skills and affect." Upon internal review the pt's mercury toxicity, neurological devastation, withdrawn/unresponsive behavior, inability to speak, repetitive behavior and loss of language skills, loss of motor skills and loss of affect were determined to be other important medical events. Further info is expected.
Age: 1.2
Sex: M
Vaccine: HEP
Symptoms: Neurodevelopmental disorder
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning an approximately 18 month old child who on 9/20/96 was vaccinated IM with hep B vaccine recombinant (lot 619858/0531D). An immunization record indicted that the pt was also vaccinated IM with Tetramune (lot 431-966 on 2/28/96); a first and second dose of Tripedia lot 7G8I484 given on 8/14/97, and lot 077I830 given on 4/24/96; one dose of HIB conjugate vaccine lot M3309L and a first and second dose of hep B vaccine lot 1950A2 given on 1/18/96 and lot 1965A2 given on 2/28/96. It was noted that all of these vaccinations contain the mercury laden preservative thimerosal. It is alleged that due to mercury toxicity that resulted from exposure to therefore mentioned vaccines, that on around July 1997, when the pt was approximately 18 months of age, he "suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior, and the loss of language skills, motor skills and affect." Upon internal review the pt's mercury toxicity, neurological devastation, withdrawn/unresponsive behavior, inability to speak, repetitive behavior and loss of language skills, loss of motor skills and loss of affect were determined to be other important medical events. Further info is expected.
Age: 0.98
Sex: M
Vaccine: HEP
Symptoms: Coma, Drug toxicity, Nervous system disorder, Social avoidant behaviour, Speech disorder
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a 12 month old male child who on 9/26/02 was vaccinated IM with two doses of hepatitis B vaccine recombinant (yeast), lot # 633031/1667J given on 9/26/00, and lot #637175/1266K given on 11/14/00. An immunization record indicated that the patient was also vaccinated IM with four doses of alum, potassium, diphtheria toxoid, pertussis vaccine, tetanus toxoid (TRIPEDIA) lot #0898570 was given on 12/2/98, lot #0970140 was given on 2/16/99, lot #6916CB was given on 5/17/99 and lot #U00401CA was given on 9/26/00; four doses of HIB conjugate vaccine (ACTHIB) lot #1001170 given on 1/16/99, lot # N081BAA given on 4/16/99, lot #N1180AA given on 6/18/99, and lot # 00421 givein on 9/26/00; and one dose of HIB conjugate vaccine (HIBTITER) lot #473814 given on 9/26/00. It was noted that all of these vaccines contained the mercury laden preservative thimerasol. It is alleged that due to the accumulation of mercury in his body and the resultant mercury toxicity, the patient on or around October 1999, when he was approximately 12 months of age, suffered neurological devastation and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including , but not limited to, becoming withdrawn, unresponsive to his environment, engaging in repetitive behavior, and the loss of language skills. Upon internal review the patient's mercury toxicity, neurological devastation, withdrawn/unresponsive behavior, repetitive behavior and loss of language skills were determined to be other important medical events. Further information is expected.
Age: 0.2
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Irritability, Pyrexia, Viral infection
Clinical narrative: Information has been received concerning a 2 month old female patient who on 1/11/02 was vaccinated with the first dose of Haemophilus B conjugate vaccine, hepatitis B vaccine recombinant (yeast) IM in the left leg (lot #639444/0776L. Concomitant therapy that same day included the first dose of diphtheria toxoid/pertussis vaccine/tetanus toxoid (INFANXRIX) IM in the right leg (lot #S16A2), the first dose of poiovirus vaccine (IPOL) SC in the right leg (lot #T1390), and the first dose of Streptococcus pneumoniae vaccine (PREVNAR) IM in the left leg (lot #484132). It was noted that sometime later, the patient became cranky and developed a fever of 104F and was admitted into the hospital. On 1/11/02, a lumbar puncture was positive for viral meningitis. Additional correspondence received on 9/4/02 from manufacturer reported that no further medically significant information was provided. No further information is available. This case is closed.